AstraZeneca, Daiichi Sankyo’s Datroway Recommended For Approval In EU As First-Line TNBC Treatment

LONDON (dpa-AFX) – AstraZeneca PLC (AZN) and Daiichi Sankyo’s Datroway has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agen…